DOT drug testing requirements for employers: 49 CFR Part 40 pre-employment rules (2026)
On this page
- Which employers must follow DOT drug testing rules?
- What does a DOT pre-employment drug test require?
- Which drugs are on the DOT panel, and at what cutoffs?
- Is the test urine or oral fluid?
- What happens between the collection and the result?
- How are refusals and dilute results handled before hire?
- How do DOT tests sit with company tests and state law?
- What records must a DOT employer keep?
- What changed in 2026?
- Checklist for hiring into a DOT safety-sensitive job
- Questions people ask
Employers regulated by the U.S. Department of Transportation must drug test their safety-sensitive employees under 49 CFR Part 40 and their own DOT agency's rule, including a pre-employment test: a truck or bus driver needs a verified negative result from a Medical Review Officer (MRO) before the first safety-sensitive function. The test covers five drug classes, is done on urine at an HHS-certified laboratory (oral fluid is authorized but no oral fluid laboratory is certified yet), and a state medical marijuana card never turns a marijuana positive into a negative, as of November 2026.
This page is the federal rulebook. For how states regulate non-DOT testing, see drug testing laws in hiring; to write a policy that keeps DOT and company testing apart, use the drug testing policy template.
Not legal advice. The rules below were checked on eCFR (Title 49, up to date as of November 10, 2026), the Federal Register and DOT's Office of Drug and Alcohol Policy and Compliance (ODAPC) as of November 2026. Your DOT agency's own rule adds details this summary leaves out. Confirm your program with the agency or counsel.
Which employers must follow DOT drug testing rules?
Part 40 sets the procedures; each operating administration decides who is covered and when tests happen. ODAPC's employer page lists six programs, and its 2026 random testing rates page sets the minimum share of covered employees each must test at random this year. The examples of covered employees come from ODAPC's notice on testing for marijuana:
| Agency | Rule | Typical covered employees | 2026 minimum random drug testing rate |
|---|---|---|---|
| FMCSA | 49 CFR Part 382 | CDL drivers of commercial motor vehicles, such as truck and school bus drivers | 50% |
| FAA | 14 CFR Part 120 | Pilots and aircraft maintenance personnel, among others | 25% |
| FRA | 49 CFR Part 219 | Train engineers and other covered service, maintenance of way and mechanical employees | 25% (covered service and maintenance of way), 50% (mechanical) |
| FTA | 49 CFR Part 655 | Subway operators and armed transit security personnel, among others | 50% |
| PHMSA | 49 CFR Part 199 | Pipeline emergency response personnel, among others | 50% |
| USCG | 46 CFR Parts 4 and 16 | Ship captains, among others | Not listed on the ODAPC rates page |
FMCSA's rule reaches every employer of a person who operates a commercial motor vehicle and needs a CDL (49 CFR 382.103), and its definition of "driver" includes casual, intermittent, leased and owner-operator drivers (382.107). Most of the examples below use FMCSA because it covers the most hires; the Part 40 steps are the same for every agency.
What does a DOT pre-employment drug test require?
- A written policy and educational materials. FMCSA employers must give each driver materials explaining the rules and the company's policy before testing begins and to every new hire (382.601).
- Tell the applicant the test is required by DOT. Section 382.113 requires notice before each test, and an employer may not label a company test as a DOT test.
- Use the federal Custody and Control Form (CCF), and no extra consent forms. DOT tests must use the CCF and must never be mixed with non-DOT tests (40.13). An employer may not make the employee sign a consent, release or waiver for any part of the testing process (40.27). ODAPC's employer page lists a revised CCF dated April 2026.
- Get a verified negative before safety-sensitive work. Under 382.301(a) the result must come from the MRO (or the employer's consortium or third-party administrator). The only exception, in 382.301(b), covers a driver who was in a compliant program within the previous 30 days and was tested within six months or was in a random pool for the previous 12 months, with no known violations in the last six months; the employer must document it.
- Check the testing history. Ask previous DOT-regulated employers for the last two years of violations with the applicant's written consent (40.25), and ask the applicant whether they failed or refused a DOT pre-employment test elsewhere in that time (40.25(j)). FMCSA employers meet the FMCSA part of this through the Clearinghouse: see the FMCSA Clearinghouse pre-employment query.
- Alcohol is optional before hire. FMCSA employers may test alcohol pre-employment only if they test every covered hire, after a contingent offer, and under Part 40 procedures (382.301(d)).
Which drugs are on the DOT panel, and at what cutoffs?
Laboratories test DOT specimens for five drug classes and nothing else (40.82). The urine cutoffs in 40.85, as of November 2026:
| Drug | Initial test cutoff | Confirmation cutoff |
|---|---|---|
| Marijuana metabolites (THCA) | 50 ng/mL | 15 ng/mL |
| Cocaine metabolite (benzoylecgonine) | 150 ng/mL | 100 ng/mL |
| Codeine and morphine | 2000 ng/mL | 2000 ng/mL each |
| Hydrocodone and hydromorphone | 300 ng/mL | 100 ng/mL each |
| Oxycodone and oxymorphone | 100 ng/mL | 100 ng/mL each |
| 6-acetylmorphine (heroin) | 10 ng/mL | 10 ng/mL |
| Phencyclidine (PCP) | 25 ng/mL | 25 ng/mL |
| Amphetamine and methamphetamine | 500 ng/mL | 250 ng/mL each |
| MDMA and MDA | 500 ng/mL | 250 ng/mL each |
Fentanyl is not on it yet. HHS added fentanyl and norfentanyl to the federal workplace panels effective July 7, 2025 (90 FR 4662) and kept them in its March 13, 2026 panel notice (91 FR 12308). DOT proposed the same change on September 2, 2025 (90 FR 42363), but as of November 2026 the 40.85 table above does not include fentanyl and we found no final rule. A DOT specimen may not be tested for anything outside the panel, so fentanyl testing of a DOT applicant would have to wait for that rule.
Is the test urine or oral fluid?
Urine, in practice. DOT's May 2023 rule (88 FR 27596, effective June 1, 2023) authorized oral fluid as an alternative, but 40.67(g)(5) lets an employer use it only once at least two laboratories are HHS-certified for oral fluid. The HHS list published November 2, 2026 (2026-22321) says there are no such laboratories, and ODAPC's oral fluid laboratory page says the same. A May 11, 2026 final rule (91 FR 25507, effective June 10, 2026) requires a directly observed urine collection where Part 40 would otherwise call for oral fluid, and gives employers 18 months after HHS certifies the second laboratory to set up oral fluid. Details: oral fluid drug testing for employers. Hair is not a DOT specimen at all: see hair follicle drug testing.
What happens between the collection and the result?
The laboratory reports only to the MRO, a licensed physician who reviews every result (40.97(c)). For a laboratory-confirmed positive, the MRO must offer the applicant an interview and verify the result as positive unless the applicant shows a legitimate medical explanation, such as a valid prescription (40.137). Three rules matter for marijuana:
- A physician's recommendation under a state medical marijuana law is not a legitimate medical explanation (40.151(e)), and neither is hemp or CBD use (40.151(f)).
- The Justice Department's order of April 28, 2026 moved FDA-approved marijuana products and state-licensed medical marijuana to Schedule III (91 FR 22714).
- DOT's Part 40 Q&A on 40.137, last updated May 15, 2026, says that "Currently, there is no instance" in which an MRO could verify such a positive as negative because of a state-licensed product: cards, recommendations and dispensary receipts do not count.
The employer's Designated Employer Representative receives verified results; positives and refusals must reach the DER the same day the MRO verifies them or the next business day (40.167). The full sequence and its time limits are in how long pre-employment drug test results take; what to do with a verified positive is in what to do when a candidate fails.
How are refusals and dilute results handled before hire?
- Walking out early is not always a refusal. An applicant who leaves before the testing process begins is not treated as refusing a pre-employment test (40.191(a)(2)). Failing to cooperate, an adulterated or substituted specimen, or refusing a directly observed collection is.
- A required medical evaluation counts only after an offer. Refusing an MRO-directed evaluation is a refusal in a pre-employment test only if the test followed a contingent offer; otherwise the MRO cancels the test (40.191(a)(7)).
- Dilute results. A positive-dilute is a verified positive. For a negative-dilute, the employer must recollect under direct observation if the MRO says so, and may otherwise retest only if it treats everyone the same way (40.197).
How do DOT tests sit with company tests and state law?
Keep them apart. A DOT test comes first and uses its own specimen; an employer may not use the federal CCF for a company test, may not run a DOT test on someone who is not DOT-covered, and may not set aside a verified DOT result because of a non-DOT result (40.13). FMCSA's rule leaves employers free to run their own additional programs under company authority (382.111) and preempts state or local rules that conflict with it (382.109). That is why state marijuana laws, summarized in marijuana drug testing laws by state, do not change DOT testing.
What records must a DOT employer keep?
| Record | Keep for | Source |
|---|---|---|
| Verified positive drug results, refusals, SAP reports, follow-up test records | 5 years | 40.333 |
| Information from previous employers under 40.25 | 3 years | |
| Negative and cancelled drug results | 1 year | |
| FMCSA Clearinghouse query records | 3 years; a valid Clearinghouse registration satisfies this since January 6, 2023 | 382.701(e) |
Test information is confidential: blanket releases are prohibited, and results go to third parties only with the employee's specific written consent or where Part 40 allows it (40.321).
What changed in 2026?
- March 4, 2026: DOT reminded SAPs and employers of the return-to-duty rules (91 FR 10518).
- April 28, 2026: the Schedule III order for FDA-approved and state-licensed medical marijuana, followed by DOT's May 15, 2026 guidance that it changes nothing for MRO verification.
- May 11, 2026 (effective June 10, 2026): the oral fluid interim rule above, which also replaced "gender" with "sex" in the observed-collection sections.
- 2026 random rates: unchanged for FMCSA at 50% for drugs; ODAPC notes the FMCSA rate last changed in 2020.
- Still pending: adding fentanyl to the DOT panel.
Checklist for hiring into a DOT safety-sensitive job
- Confirm the job is covered by a DOT agency rule, and which one.
- Give the applicant your DOT policy and say the test is DOT-required.
- Send the applicant for a urine collection on the federal CCF, separate from any company test.
- Run the previous-employer check (and, for CDL drivers, the Clearinghouse full query) with written consent.
- Wait for the MRO's verified negative before any safety-sensitive work.
- Keep the records for the periods above, apart from interview notes and personnel files.
Staffing firms placing drivers should also read drug testing for staffing agencies, which covers who acts as the DOT employer when an agency supplies the driver. Recruiters screening drivers can use the truck driver screening questions.
Questions people ask
Does a DOT pre-employment drug test have to be done before the driver starts work?
Yes. Under 49 CFR 382.301, an FMCSA-regulated employer may not let a driver perform safety-sensitive functions until it has received a verified negative controlled substances result from the Medical Review Officer, unless the narrow exception for drivers recently in a compliant testing program applies, as of November 2026.
Can a DOT employer use a mouth swab instead of a urine test?
Not yet. Part 40 has allowed oral fluid testing since June 1, 2023, but only once at least two laboratories are HHS-certified for oral fluid, and the HHS list published November 2, 2026 says no laboratory is certified to test oral fluid. DOT employers therefore still use urine.
Is fentanyl on the DOT drug test panel?
Not as of November 2026. HHS added fentanyl to the federal workplace panels effective July 7, 2025, and DOT proposed adding fentanyl and norfentanyl in September 2025, but the cutoff table in 49 CFR 40.85 on eCFR still lists only marijuana, cocaine, opioids, phencyclidine and amphetamines, and we found no final rule.
Can a medical marijuana card excuse a positive DOT drug test after rescheduling?
No. DOT's Part 40 guidance dated May 15, 2026 says a Medical Review Officer cannot verify a laboratory-confirmed marijuana positive as negative because of a state medical marijuana card, a physician recommendation or dispensary records, even after the April 28, 2026 order moving state-licensed medical marijuana to Schedule III.
Do state marijuana laws apply to DOT drug tests?
No. FMCSA's rule, 49 CFR 382.109, preempts state or local laws that make compliance impossible or stand in the way of the federal rule, and state cannabis statutes such as Nevada's and Connecticut's carve out jobs that federal law requires to be tested.